Cargando…
Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial
BACKGROUND: Currently, coronavirus disease 2019 (COVID-19) is continuously and rapidly circulating, causing heavy damage on public health. No effective antiviral treatment has been proved thus far. Traditional Chinese medicine (TCM) has been widely applied in the treatment of a variety of infection...
Autores principales: | Fang, Bangjiang, Zhang, Wen, Wu, Xinxin, Huang, Tingrong, Li, Huacheng, Zheng, You, Che, Jinhua, Sun, Shuting, Jiang, Chao, Zhou, Shuang, Feng, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312108/ https://www.ncbi.nlm.nih.gov/pubmed/32580752 http://dx.doi.org/10.1186/s13063-020-04498-6 |
Ejemplares similares
-
Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial
por: Zhang, Wen, et al.
Publicado: (2021) -
Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: A randomized controlled multicenter trial
por: Zhou, Shuang, et al.
Publicado: (2021) -
Clinical Effect of Traditional Chinese Medicine Shenhuang Granule in Critically Ill Patients with COVID-19: A Single-Centered, Retrospective, Observational Study
por: Feng, Jun, et al.
Publicado: (2021) -
Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking
por: Xu, Xiang-ru, et al.
Publicado: (2022) -
A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)
por: Tomita, Noriko, et al.
Publicado: (2022)